CV Sciences, Inc. (CVSI)

CV Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	16	16.21	20.05	24.43	53.7
Revenue Growth (YoY)	-1.24%	-19.17%	-17.93%	-54.50%	11.30%
Cost of Revenue	8.92	10.66	11.43	13.42	18.61
Gross Profit	7.09	5.55	8.62	11.01	35.09
Selling, General & Admin	9.39	12.09	25.88	30.66	46.45
Research & Development	0.15	0.31	1.19	2.94	5.88
Operating Expenses	9.55	12.4	27.06	33.6	52.33
Operating Income	-2.46	-6.85	-18.45	-22.59	-17.24
Interest Income	0	1.54	0.14	0.01	0.02
Interest Expense	0	1.54	0.14	0.01	-0.02
Other Expense / Income	-5.56	1.41	-2.81	0.01	0.02
Pretax Income	3.1	-8.26	-15.64	-22.6	-17.23
Income Tax	-0.01	-0.05	-0.09	-0.32	-0.62
Net Income	3.1	-8.21	-15.55	-22.28	-16.61
Shares Outstanding (Basic)	154	138	108	100	98
Shares Outstanding (Diluted)	154	138	108	100	98
Shares Change	11.53%	28.03%	7.91%	2.10%	-14.51%
EPS (Basic)	0.02	-0.06	-0.14	-0.22	-0.17
EPS (Diluted)	0.02	-0.06	-0.14	-0.22	-0.17
Free Cash Flow	2.25	-1.89	-7.52	-8.36	-3.37
Free Cash Flow Per Share	0.01	-0.01	-0.07	-0.08	-0.03
Gross Margin	44.27%	34.25%	42.98%	45.07%	65.35%
Operating Margin	-15.37%	-42.25%	-92.01%	-92.48%	-32.11%
Profit Margin	19.38%	-50.69%	-77.58%	-91.22%	-30.93%
Free Cash Flow Margin	14.08%	-11.63%	-37.51%	-34.21%	-6.28%
Effective Tax Rate	-0.19%	-	-	-	-
EBITDA	-2.23	-5.86	-17.29	-21.72	-16.52
EBITDA Margin	-13.90%	-36.13%	-86.26%	-88.91%	-30.77%
Depreciation & Amortization	0.24	0.99	1.15	0.87	0.72
EBIT	-2.46	-6.85	-18.45	-22.59	-17.24
EBIT Margin	-15.37%	-42.25%	-92.01%	-92.48%	-32.11%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.